Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherRent ExpenseShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesWages, Salaries and Other
Ratios

Cannabis Bioscience International Holdings (CBIH) Short-Term Debt repayments (2024 - 2025)

Cannabis Bioscience International Holdings' Short-Term Debt repayments history spans 2 years, with the latest figure at -$56274.0 for Q1 2025.

  • On a quarterly basis, Short-Term Debt repayments fell 196.18% to -$56274.0 in Q1 2025 year-over-year; TTM through Feb 2025 was $417041.0, a 2294.95% increase, with the full-year FY2024 number at $398041.0, changed N/A from a year prior.
  • Short-Term Debt repayments hit -$56274.0 in Q1 2025 for Cannabis Bioscience International Holdings, down from -$12852.0 in the prior quarter.
  • Over the last five years, Short-Term Debt repayments for CBIH hit a ceiling of $417041.0 in Q2 2024 and a floor of -$56274.0 in Q1 2025.